Key points are not available for this paper at this time.
There are delays in treatment intensification in people with type 2 diabetes despite suboptimal glycemic control. A substantial proportion of people remain in poor glycemic control for several years before intensification with OADs and insulin.
Khunti et al. (Tue,) studied this question.